Adapted CBT-I for Insomnia
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new version of cognitive behavioral therapy for insomnia (CBT-I), delivered over the phone, targeting individuals who drink alcohol at hazardous levels and struggle with insomnia. The goal is to determine if this treatment is practical to deliver and effective in reducing both alcohol use and insomnia severity. Participants will either receive this therapy or join a control group that receives general education on sleep and alcohol. This trial may suit individuals living in New York State who drink more than the recommended limit and have ongoing insomnia issues. As an unphased trial, it offers a unique opportunity to contribute to innovative research that could improve treatment options for insomnia and alcohol use.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, if you are undergoing oncology treatment or have a serious medical condition, you may be excluded from participating.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that cognitive-behavioral therapy for insomnia (CBT-I) is safe and manageable. Studies have found that CBT-I can improve sleep problems without causing side effects. Unlike some sleep medications, CBT-I carries a lower risk of relapse, allowing people to maintain good sleep over time. This means unexpected issues are unlikely with CBT-I.
Overall, CBT-I is considered a safe option for those struggling with insomnia, even for individuals who consume alcohol.12345Why are researchers excited about this trial?
Researchers are excited about this treatment because it adapts cognitive-behavioral therapy for insomnia (CBT-I) specifically for individuals who also have hazardous alcohol use. Unlike standard CBT-I, which focuses solely on sleep issues, this version also addresses the impact of alcohol on sleep, potentially making it more effective for this unique group. Delivered through four telephone-based sessions over six weeks, it offers a convenient and accessible way to tackle insomnia, especially for those who might struggle with traditional in-person therapy sessions.
What evidence suggests that this trial's treatments could be effective for insomnia and alcohol use?
Research shows that Cognitive Behavioral Therapy for Insomnia (CBT-I), which participants in this trial may receive as part of the Insomnia Treatment arm, effectively treats insomnia. Studies have found that CBT-I greatly reduces insomnia severity. It works as well as sleep medications but without side effects, and it often helps people continue improving their sleep over time. CBT-I also benefits those with other health issues, making it potentially helpful for individuals with both insomnia and alcohol use problems. In summary, evidence strongly supports CBT-I as a reliable treatment option for better sleep.12567
Who Is on the Research Team?
Wilfred R Pigeon, PhD
Principal Investigator
University of Rochester
Are You a Good Fit for This Trial?
This trial is for adults in Monroe County, NY or nearby who drink more alcohol than low-risk guidelines suggest and have insomnia. They must speak English and not be getting treatment for alcohol issues, pregnant, planning pregnancy soon, or using IV drugs. People with serious medical conditions or significant sleep disorders other than insomnia are also excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Pilot
A small, open label pilot to develop and refine procedures for administering the intervention
Randomized Trial
A small randomized trial comparing the intervention to a sleep and alcohol education control condition
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Education Control
- Insomnia Treatment
Insomnia Treatment is already approved in United States for the following indications:
- Insomnia
- Alcohol Use Disorder (as adjunct therapy)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Rochester
Lead Sponsor